Work

TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC

Year: 2015

Type: article

Source: Kölner Universitäts PublikationsServer (Universität zu Köln)

Authors: D. Ross Camidge, Federico Cappuzzo, Jowell Go, Jeffrey D. Isaacson, Jason B. Litten, Keunchil Park, David R. Spigel, Alexander I. Spira, A. Vergnenègre, Juergen Wolf, James Chih‐Hsin Yang, Tony Mok, 楊志新

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3209591334

FWCI:

Cites:

Cited by:

Related to: 10